WEIKANG BIO-TECHNOLOGY GROUP CO., INC. - FORM 10-K - EX-32.1 - EXHIBIT 32.1 - March 31, 2010

Attached files

file filename
10-K - WEIKANG 10-K 12.31.09 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC.form10-k.htm
EX-23.2 - EXHIBIT 23.2 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC.ex23_2.htm
EX-31.1 - EXHIBIT 31.1 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC.ex31_1.htm
EX-31.2 - EXHIBIT 31.2 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC.ex31_2.htm
EX-23.1 - EXHIBIT 23.1 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC.ex23_1.htm
EX-32.2 - EXHIBIT 32.2 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC.ex32_2.htm
 
Exhibit 32.1
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
 
In connection with the Annual Report of Weikang Bio-Technology Group Co., Inc. (the "Company") on Form 10-K for the year ended December 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Yin Wang, our Chief Executive Officer, certifies, pursuant to 18 U.S.C. 1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, based on my knowledge:
 
 
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2)
The information contained in the Report fairly presents, in all material respects, our financial condition and result of operations.
 
 
     
 
WEIKANG BIO-TECHNOLOGY GROUP CO., INC.
(Registrant)
     
Date: March 31, 2010
By:
/s/ Yin Wang
Yin Wan
 
Chief Executive Officer

 

 
 

WEIKANG BIO-TECHNOLOGY GROUP CO., INC. Reports